Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients

NCT07114276 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.

NCT NCT07114276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07114276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients
Lead sponsor
Taipei Medical University
Phase
Observational
Overall status
Completed
Start date
October 30, 2023
Completion date
November 30, 2025
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney disease, acute kidney injury, chemotherapy side effects, machine learning